Researchers establish fetal brain organoids as a versatile platform for brain cancer modeling.
Mindset Pharma At MAPS: Phase 2 In-Patient Trial And More
[embedded content] In this latest TDR Exclusive podcast: We’re on location at the MAPS Psychedelics Science Conference with Mindset Pharma. Mindset Co-founder and Chief Scientific